These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 14598019)

  • 1. Impact of genetic polymorphisms in transmembrane carrier-systems on drug and xenobiotic distribution.
    Gerloff T
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Jan; 369(1):69-77. PubMed ID: 14598019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of genetic polymorphisms in drug transporters for pharmacotherapy.
    Kerb R
    Cancer Lett; 2006 Mar; 234(1):4-33. PubMed ID: 16504381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xenobiotic, bile acid, and cholesterol transporters: function and regulation.
    Klaassen CD; Aleksunes LM
    Pharmacol Rev; 2010 Mar; 62(1):1-96. PubMed ID: 20103563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro-in vivo extrapolation of transporter-mediated clearance in the liver and kidney.
    Kusuhara H; Sugiyama Y
    Drug Metab Pharmacokinet; 2009; 24(1):37-52. PubMed ID: 19252335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of genetic polymorphism on the activity of drug transporters and its clinical significance].
    Zhang HX; Wang LS
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 33(8):765-9. PubMed ID: 18772522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies.
    Roth M; Obaidat A; Hagenbuch B
    Br J Pharmacol; 2012 Mar; 165(5):1260-87. PubMed ID: 22013971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organic anion transporters and their implications in pharmacotherapy.
    Emami Riedmaier A; Nies AT; Schaeffeler E; Schwab M
    Pharmacol Rev; 2012 Jul; 64(3):421-49. PubMed ID: 22457399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Transporters in Xenobiotic Disposition and Pharmacokinetic Prediction.
    Mao Q; Lai Y; Wang J
    Drug Metab Dispos; 2018 May; 46(5):561-566. PubMed ID: 29636376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genetic polymorphism of drug transporters: functional analysis approaches.
    Ishikawa T; Tsuji A; Inui K; Sai Y; Anzai N; Wada M; Endou H; Sumino Y
    Pharmacogenomics; 2004 Jan; 5(1):67-99. PubMed ID: 14683421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organic Anion Transporter 2: An Enigmatic Human Solute Carrier.
    Shen H; Lai Y; Rodrigues AD
    Drug Metab Dispos; 2017 Feb; 45(2):228-236. PubMed ID: 27872146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transporters and their impact on drug disposition.
    Beringer PM; Slaughter RL
    Ann Pharmacother; 2005 Jun; 39(6):1097-108. PubMed ID: 15886292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane transporter proteins: a challenge for CNS drug development.
    Girardin F
    Dialogues Clin Neurosci; 2006; 8(3):311-21. PubMed ID: 17117613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption.
    Shitara Y; Maeda K; Ikejiri K; Yoshida K; Horie T; Sugiyama Y
    Biopharm Drug Dispos; 2013 Jan; 34(1):45-78. PubMed ID: 23115084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SLC Family Transporters.
    Liu X
    Adv Exp Med Biol; 2019; 1141():101-202. PubMed ID: 31571165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview: Role of Drug Transporters in Drug Disposition and Its Clinical Significance.
    Liu X
    Adv Exp Med Biol; 2019; 1141():1-12. PubMed ID: 31571163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Progress in the gene polymorphisms of drug-related transporters].
    Li D; Zhang GL
    Sheng Li Ke Xue Jin Zhan; 2005 Jul; 36(3):245-8. PubMed ID: 16270827
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of drug-transporter interactions using in vitro and in vivo models.
    Xia CQ; Milton MN; Gan LS
    Curr Drug Metab; 2007 May; 8(4):341-63. PubMed ID: 17504223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenomics of the OATP and OAT families.
    Marzolini C; Tirona RG; Kim RB
    Pharmacogenomics; 2004 Apr; 5(3):273-82. PubMed ID: 15102542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Transporter Polymorphisms on Drug Development: Is It Clinically Significant?
    McLean C; Wilson A; Kim RB
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S40-58. PubMed ID: 27385178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug transporters in the lung--do they play a role in the biopharmaceutics of inhaled drugs?
    Bosquillon C
    J Pharm Sci; 2010 May; 99(5):2240-55. PubMed ID: 19950388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.